1. About Prostate Cancer. American Cancer Society 2016. https://www.cancer.org/content/dam/CRC/PDF/Public/8793.00.pdf
2. Esen T, Turkbey B, Patel A, Futter J. Multiparametric MRI in Prostate Cancer. BioMed Research International. 2014 Hindawi Publishing Corporation.
3. Purysko A, Rosenkrantz A, Barentsz, Weinreb J, Macura K. PI-RADS Version 2: A Pictorial Update. RadioGraphics: Volume 35 Number 5.
4. Revisions in PI-RADS v2.1 Presentation. European Society of Urogenital Radiology. American College of Radiology.
5. Steiger P, Thoeny H. Prostate MRI based on PI-RADS version 2: how we review and report. Cancer imaging (2016) 16:9.
6. Tae j, Sankinei S, Xu S, Trukbey B, Choyke P, et al. Prostate Cancer: A Correlative Study of Multiparametric MR Imaging and Digital Histopathology. Radiology.
7. Thornbury JR, Ornstein DK, Choyke PL, Langlotz CP, Weinreb JC. Prostate Cancer: What is the future for imaging? Am J Roentgenology 2001; 176:17‐22.
8. Turkbey, Baris et al. Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2. European Urology, Volume 76, Issue 3, 340 – 351.
9. Turkbey B, Pinto P, Mani H, Bernardo M, Pang Y, et al. Prostate Cancer: Value of Multiparametric MR Imaging at 3 T for Detection- Histopathologic Correlation. Radiology: Volume 255: Number 1-April 2010. Radiology/.rsna.org
10. Vargas HA, Akin O, Franiel T, Goldman DA, Udo K, et al. Normal cnetals zone of the prostate and central zone involvement by prostate cancer: clinical and MR imaging implications. Radiology 2012;262:894‐902
11. Villers A, Lemaitre L, Haffner J, Puech P. Current status of MRI for the diagnosis, staging and prognosis of prostate cancer: implications for focal therapy and active surveillance. Curr Opin Urol 2009;19:274‐82
12. Weinreb, J.C., Barentsz, J.O., Choyke, P.L. et al. PI-RADS Prostate Imaging - Reporting and Data System, v2.1: 2019. American College of Radiology.